Valeda ™ is the first photobiomodulation (PBM) device designed specifically for eye conditions such as dry age-related macular degeneration.
What is age-related macular degeneration?
Age-related macular degeneration (AMD) is a common condition affecting older people and usually starting around 50-60 years of age. This condition results in deterioration of the central part of your vision when the macular retina develops lesions. There are two main types called dry and wet AMD. Dry age-related macular degeneration is more common than wet AMD. Dry AMD is caused by the build up of drusen, which a fatty deposit, at the back of the eye or retina. Wet AMD is caused by the growth of abnormal blood vessels at the back of the eye.
Valeda ™ Light Delivery System
The Valeda ™ Light Delivery System (LDS) was developed by LumiThera. The system is the first approved treatment for dry age-related macular degeneration (AMD) using photobiomodulation (PBM). PBM has been around for a long time and used for number of different conditions including muscle repair; wound healing; improve muscle performance and many other applications. PMB uses light to stimulate cells. This stimulates energy production within cells improving their function.
Frequently Asked Questions
The consultant ophthalmologist will assess each individual for suitability for Valeda. The Valeda treatment is used for patients with dry age-related macular degeneration with visual impairment. There have been some promising results with the use of Valeda in the early stages of dry AMD to prevent or delay progression of AMD.
You will need to remove glasses and contact lenses prior to your treatment. You will not require any special eye drops for this treatment. The treatment involves sitting in front of the Valeda Light Delivery System similar to when you have your eye examined at the optician.
You will normally require a course of treatments. You will usually have 1 treatment 3 times a week for 3 weeks. If you miss a session you can make up for this within the 3-4 week course period.
Valeda treatment is a form of photobiomodulation which is a low level light therapy to help cells improve their function. This technique of photobiomodulation has been used for other diseases and conditions. The clinical studies and research have shown this to be safe procedure. There may be some patients that may not respond or in whom this may not be effective.
When you have been exposed to bright light for a length of time, this may cause photobleaching. This is when the red colours appear more faded and you will see more of the opposite colour which is green. This usually improves after a few minutes following the treatment.
The price for Valeda is usually based on a 3 week course of 3 treatments per week. The price for a 3 week course is £2350. This is performed by a consultant ophthalmologist in our Cheshire based clinic in Knutsford.